Navigation Links
Fighting a Fungus That Thrives on Tomatoes
Date:5/9/2008

Scientists find disease-resistant gene wards off fusarium wilt on leaves

FRIDAY, May 9 (HealthDay News) -- A molecular-based approach to helping tomatoes fight a fungus that causes wilt has been identified by Dutch scientists.

In agriculture, there's an ongoing battle against the ability of plant pathogens to co-evolve along with their host plant's immune system, according to background information in the study. One way to increase protection is through disease resistance genes that strengthen a plant's immune system.

In this study, the researchers looked at tomatoes and the fungal pathogen Fusarium oxysporum, which causes fusarium wilt disease.

The University of Amsterdam team found that a suppressor protein secreted by some strains of the fungus enables it to overcome two of the tomato plant's disease resistance genes. However, a third resistance gene specifically targets the suppressor protein, making the plant fully resistant to any fungal strain that produces the protein.

This means that with the right set of resistance genes, tomato plants can defeat the fungus.

"This molecular analysis has revealed a hitherto unpredicted strategy for durable disease control based on resistance combinations," according to a news release about the study, published Friday in the journal PLoS Pathogens.

More information

Ohio State University has more about fusarium wilt.



-- Robert Preidt



SOURCE: Public Library of Science, news release, May 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Study shines more light on benefit of vitamin D in fighting cancer
2. Cities Say Restaurant Nutrition Information Crucial in Fighting Obesity
3. Elliot Yamin: Fighting Diabetes
4. Their immune cells, fighting your cancer
5. Clean Hands are Key to Fighting Cold, Flu Germs
6. Fighting the Gassy Effects of Good Eating, From the Harvard Health Letter
7. Family Infighting Hurts the Heart
8. The Power of Community in Fighting HIV/AIDS Among Latinos
9. Fighting obesity may be as easy as ATP, says UH researcher
10. Handwashing, Masks Beat Drugs at Fighting Flu
11. Germ-Fighting Inhaler Could Fend Off Bioterror Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ynchronized Slides at 5pm Today, LAWRENCE, Mass.,... Inc.,(Nasdaq: NXTM ), a leading manufacturer of ...financial results for the first quarter ended Marc...08 were $31.0 million, compared to,$8.4 million in...e fourth,quarter of 2007. Revenues in the in-cente...
(Date:5/12/2008)...all/ - SXC Health Solutions, Corp.,(NASDAQ: SXCI ...ts,management services and healthcare IT solutions...Shareholders will be held on Monday, May 12, 2008 ...t the Marriott Downtown, 540,North Michigan Avenue...bcast live. To access the webcast go to:, http:/...
(Date:5/12/2008)...inia Commonwealth University School of Medicine ha...million from the National Institutes of Healths Na...nt to examine polycystic ovary syndrome, a disorde...5 million women. , Polycystic ovary syndrome, or...ular menstrual cycles, excess facial and body hair...
(Date:5/12/2008)...y safety and quality of technically ...ay 12 /PRNewswire/ -- C5 Medical Werks, a leading ...ce industry, has submitted a 510(k),pre-market not... (FDA) for,its new technical ceramic dental compon...zirconium material ideally suited to meet the high...
Breaking Medicine News(10 mins):Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:NIH grant to support Translational Research Center for PCOS 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2
...k of Hepatitis-A among students of Jiangxi Univers...cern to health officials in the province.// This ... resulted in the hospitalization of 64 students, a... Xinhua News Agency reports that the students who ...
...dvances in technology, new high technology based t...re is being designed by researchers of Johns Hopki...ole medical procedure a lot more safe and effectiv...t that could enable surgeons, operating in the nar...
...s at the University of Pennsylvania School of Medi... translates blood flow into gene expression. The//...ryonic development a transcription factor called K...ls, is activated by rapid, pulsed blood flow, as r...
...a government Wednesday amended the rules governing... in a bid to regulate them.// The state cabinet d...f school managements, students and employees, an o...ool managements will now be required to provide ad...
Other Medicine News:Health News:Snake Like Robots Designed to Assist Surgeons 2Health News:Snake Like Robots Designed to Assist Surgeons 3Health News:How Blood Flow Dictates Gene Expression 2
(Date:5/8/2008).../- Globus Medical, Inc., the largest,...world and a recognized,leader in motion preservati...nrollment in its SECURE(R)-C Cervical Artificial D...to mimic the normal motion of the spine in,order t...ative to fusion in,the treatment of symptomatic ce...
(Date:5/8/2008)...ty data support potential of asenapine in the trea...r I disorder, WASHINGTON, May 8 /PRNewswire-First... today announced that an overview of asenapine cli...d at the 161st Annual Meeting of the,American Psyc...Data from,the studies, involving patients with bip...
(Date:5/8/2008)...vides "Blueprint" to Produce Therapeutic Proteins ...PRNewswire-USNewswire/ -- Using gene,therapy, plas...ns through,skin flaps placed on cancerous tumors o..., according to a study in the May issue of Plastic...al journal of the American,Society of Plastic Surg...
(Date:5/8/2008)...sentations to Focus on Use of Pro-Healing Stent wi...ual-Antiplatelet Therapy, HONG KONG, May 8 /PRNew...randomized pilot study and the real-world registry..., the world,s first pro-healing stent, will be,pre... Barcelona, Spain., The symposium, titled "Clinic...
Breaking Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 1Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 2Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 3Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 1Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 2Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 3Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 1Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 2Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 3Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 4Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 5Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 1Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 3
...Impact of Pain on Sleep Interference, INDIANAPOLIS... a,pooled analysis of three studies suggest that i...ge, or diabetic peripheral neuropathy,who are tre...in,both average daily pain and night pain severity...rference than in those patients,taking sugar pill....
.../PRNewswire/ -- Bayer HealthCare,Pharmaceuticals a...es with Betaseron(R) (interferon beta-1b), present...s (AAN) 59th Annual Meeting,demonstrating early e...satisfaction with treatment in patients with relap...vely, these studies highlight the important clinic...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
Alcon offers medical grade perfluoropropane (SF6) intraocular gases for ophthalmological use.
Highly concentrated daily cleaner with Microclens beads for superior cleaning action.
Bausch & Lomb concentrated cleaner is a sterile, concentrated homogeneous surfactant solution containing alkyl ether sulfate, ethoxylated alkyl phenol, tri-quaternary cocoa-based phospholipid and sil
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses.
Medicine Products: